NextPoint Therapeutics
Bispecific T cell engaging antibodies targeting hematologic cancers
- Sector
- Biotech
- Founded
- 2018
- Latest Form D
- $42.5M, Feb 2024
- Total capital
- $122M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $122M
- 2 Form D · last Feb 2024
- 32 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 18 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$42.5M
- Private capital raisedForm D · SEC · 1st filing$80M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Ansbert GadickeDirectorNamed in SEC Form D filings
- Axel HoosDirectorNamed in SEC Form D filings
- Detlev BiniszkiewiczExecutive Officer, DirectorNamed in SEC Form D filings
- Ivan CheungExecutive Officer, DirectorNamed in SEC Form D filings
- Matthew RodenDirectorNamed in SEC Form D filings
- Matthew Roden)DirectorNamed in SEC Form D filings
Show all 10 people
- Paul ConradExecutive OfficerNamed in SEC Form D filings
- Paulina HillDirectorNamed in SEC Form D filings
- Rakhshita DharDirectorNamed in SEC Form D filings
- R. Jacob VogelsteinDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 18- PendingHHLA2 Binding Agents With Novel ActivityUSPTOApplication 18263313
- PendingKIR3DL3 Inhibitors And Immune Cell Activating AgentsUSPTOApplication 18839953
- PendingT Cell And Nk Cell EngagersUSPTOApplication 18836996
Show all 18 patent records
- HHLA2 Binding Agents With Novel ActivityAug 28, 2025 · Application 18263313Pending
- KIR3DL3 Inhibitors And Immune Cell Activating AgentsMay 29, 2025 · Application 18839953Pending
- T Cell And Nk Cell EngagersMay 1, 2025 · Application 18836996Pending
- Multispecific Antibodies Or Antigen Binding Fragments Thereof To HHLA2 And Immune Effector Cell AntigensApplication 63554065Pending
- Antibody-drug ConjugatesApplication 63550023Pending
- HHLA2 Binding ConjugatesApplication 63591078Pending
- HHLA2 Binding ConjugatesApplication 63581306Pending
- KIR3DL3 Inhibitors And Immune Cell Activating AgentsApplication PCTUS2023013537Pending
- T Cell And Nk Cell EngagersApplication PCTUS2023012836Pending
- KIR3DL3 Inhibitors And Immune Cell Activating AgentsApplication 63418105Pending
- KIR3DL3 Inhibitors And Immune Cell Activating AgentsApplication 63312507Pending
- T Cell And Nk Cell EngagersApplication 63308800Pending
- HHLA2 Binding Agents With Novel ActivityApplication PCTUS2022014423Pending
- HHLA2 Binding Agents With Novel ActivityApplication 63142832Pending
- Multispecific Antibodies Or Antigen Binding Fragments Thereof To B7-H7 And Immune Effector Cell AntigensApplication PCTUS2025015857Pending
- Antibody-drug ConjugatesApplication 19516879Pending
- Multispecific Antibodies Or Antigen Binding Fragments Thereof To HHLA2 And Immune Effector Cell AntigensApplication 63712349Pending
- Antibody-drug ConjugatesApplication PCTUS2024045733Pending
Related companies, and why
- Terrestrial Bio, Inc.Similar federal contract value in Biotech · null in contracts
- iTeos TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Star TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Quanta Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- UroGen Pharma Ltd.Similar federal contract value in Biotech · null in contracts
- ANAGINSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .